S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Home
Investing
Stocks
Brazil
BOV
Option Care Health Inc. (O2PC34)
Option Care Health Inc. (O2PC34) News

Option Care Health Inc. (O2PC34)

0.00

0.00

(0.00%)

Closed 13 July 6:55AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

0 articles were found

Juststoppingby

Juststoppingby 1 minute ago

My AI responds to clarification on “EDGAR packages are being validated”.

When I say “EDGAR packages are being validated,” I’m talking about a very specific, very technical stage in the SEC-filing process — one that happens right before a delinquent filer begins submitting forms.

zakattack

zakattack 3 minutes ago

They put out a pr dec 2025 stating they would increase to 49% in gncp but no filings proving they actually did so sp again where is the proof pdiv paid anything or did anything for the land claims prove me wrong

nowwhat2

nowwhat2 6 minutes ago

mikeo56

mikeo56 7 minutes ago

Smoking in Aussie land .
Up 30 %
Tomorrow in USA will be good.

choo choo trader

choo choo trader 10 minutes ago

Thanks for reposting it Striper, somehow I missed it when gdog initially posted it. That is about the most informative video I have seen so far laying out the whole risk/reward story of $NLST.

ron_66271

ron_66271 11 minutes ago

No The FDIC and JPM both Had a Claim Against $24 Billion.

Inflated claim of $27*2=$54.00 Billion against the Estate to make WMI as insolvent for the Senior Note holders when JPM controlled the BK process because invested in the Senior Notes of WMI with the takeover.

skitahoe

skitahoe 11 minutes ago

Doc, I've been saying this for ages, but not that the full EDEN based facility must be completed. I believe the UK and other countries would simply like to know it's close. They'd like to know the EDEN is making commercial quality vaccine and that it can be delivered in quantity, and they'd like t

FDA-agent-2

FDA-agent-2 15 minutes ago

nobody is getting paid here .no editiing or no research which cost money.

Johnnycombat10

Johnnycombat10 16 minutes ago

I see both sides of the debate . The company has every right to state their position just as you have your right to speak yours. But you have right to demand anything from anyone on this board. You have no rights other than the right to speak our mind. And I have the to tell you to pound salt. If I

AstroGuru64

AstroGuru64 17 minutes ago

The issue still lies with the Treasury Department.

FDA-agent-2

FDA-agent-2 20 minutes ago

too much fake news on facebook, yahoo,and youtube these. and tabloid news or censored news.
sites like google, yahoo. facebook cannot get the content for cheap anymore or they won't even license it to them, it used to be free or very cheap to promote their newsight but they don't nobody ever

Truthsocial

Truthsocial 23 minutes ago

Vivos Inc. received U.S. FDA approval for the Investigational Device Exemption (IDE) for RadioGel® on July 6, 2026, which permits the initiation of the first-in-human feasibility study at Mayo Clinic in Jacksonville, FL.

While the FDA IDE approval has been granted, the study protocol

gfp927z

gfp927z 23 minutes ago

New York Times - >>> In the fourth quarter of 2025, Berkshire Hathaway acquired about 5.1 million shares of The New York Times Company, taking a roughly 3% stake valued at $350–$352 million. This was the first time Berkshire had invested in a newspaper since selling off its holdings in 2020. The mov

uber darthium

uber darthium 24 minutes ago

DBSCAM’em

A Linda Poory SCAM for over 2 decades

Can’t wait to read that filing this week

Ought to make for some good SCAM reading

DBSCAM’em

Noted and Always Correct

zerosnoop

zerosnoop 24 minutes ago

All the GEMS & FACTS are in the latest 10Q filing. The PROVEN AOT is going GLOBAL.

We are now focusing on a potential sale of 150 units as an initial purchase order under the so-called Laksel LOI (discussed below). This represents a defined India focused initial program wit

gfp927z

gfp927z 26 minutes ago

New York Times - >>> In the fourth quarter of 2025, Berkshire Hathaway acquired about 5.1 million shares of The New York Times Company, taking a roughly 3% stake valued at $350–$352 million. This was the first time Berkshire had invested in a newspaper since selling off its holdings in 2020. The mov

raggi65

raggi65 26 minutes ago

Do you have a link to the discovery document filed by Quinn Emanuel?
825 pages – that sounds as though there might be plenty of useful arguments in there, and with a citable reference, they would be all the more compelling

juicyjuice10002

juicyjuice10002 29 minutes ago

Yes, Executive Order 14393 is widely expected to help Fannie Mae (FNMA) and Freddie Mac (FMCC) by laying the regulatory groundwork for their eventual exit from government conservatorship.

While much of the public text targets community banks, the order contains specific directives fo

chuck1418

chuck1418 33 minutes ago

volume is picking up and shares are turning over. this week could be a breakout if we can go and sustain doubles

DrivenByPain

DrivenByPain 34 minutes ago

$SNTX! LMMFAO! More Then Just Nice Volume Here My Boy .

RED44

RED44 38 minutes ago

Should have said accountant rather than auditor.

georgejjl

georgejjl 41 minutes ago

Alzheimer's Association International Conference®

July 12-15, 2026

Look at the 2026 Silver Sponsers

https://aaic.alz.org/role/sponsor.asp

Good luck and GOD bless,

mikepgator

mikepgator 44 minutes ago

https://x.com/pennystockluvr/status/2076479569289441491?s=46&t=MxR4z7pPou_0usGfqAHGvQ

bigtalan

bigtalan 47 minutes ago

Not sure if anyone has asked AI and then followed the rabbit hole but interest read
is there any current updates on any new research from RespireRx Pharmaceuticals IncRespireRx Pharmaceuticals Inc. is actively advancing two primary drug platforms. Recent updates include a U.S. Department of

COminer

COminer 50 minutes ago

I'd say we are, LOL

Option Care Health

CAMIL ALIMENTOS ON

Polska Grupa Odlewnicza

Regular Interest Fixed C...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN

Already have an account? Sign in

Don't have an account? Sign up

By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.